Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Sanofi Pulls Leukaemia Drug Ahead of Possible OK for Lemtrada
Aug. 21, 2012
Sanofi's rare disease unit Genzyme is pulling leukaemia drug Campath to prepare for its launch under a different dosage and as a multiple sclerosis treatment that will be branded as Lemtrada.
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing